Ischemia Reperfusion Injury Market Report

Global and Region Ischemia Reperfusion Injury Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：171
  • REPORT CODE：GMM918580
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

    The report details the trend, potential and market size of Ischemia Reperfusion Injury market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Ischemia Reperfusion Injurymarket, defines the market attractiveness level of Ischemia Reperfusion Injury market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Ischemia Reperfusion Injury industry, describes the types of Ischemia Reperfusion Injury market, the applications of major players and the market size, and deeply analyzes the current situation of the global Ischemia Reperfusion Injury market and the development prospects and opportunities of Ischemia Reperfusion Injury industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Ischemia Reperfusion Injury market in Chapter 13.

    By Player:

    • Pharming

    • Bolder Biotechnology

    • SBI Pharmaceuticals

    • Opsona Therapeutics

    • TheraSource

    • Mifcortx

    • Prothix

    • Balmes Transplantation

    • Angion Biomedica

    • Ischemix Inc

    • Corline Biomedical

    • Hope Pharmaceuticals

    • NovelMed Therapeutics

    • Omeros Corp

    • Catalyst Biosciences

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • Heart Injury

    • Kidney Injury

    • Intestine Injury

    • Other Injury

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Ischemia Reperfusion Injury Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Ischemia Reperfusion Injury Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Ischemia Reperfusion Injury Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Ischemia Reperfusion Injury Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Ischemia Reperfusion Injury Market Analysis and Outlook to 2022

    • 7.1 Global Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.2 United States Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.3 Europe Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.4 China Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.5 Japan Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.6 India Ischemia Reperfusion Injury Consumption (2017-2022)

    • 7.7 South Korea Ischemia Reperfusion Injury Consumption (2017-2022)

    8 Region and Country-wise Ischemia Reperfusion Injury Market Analysis and Outlook to 2028

    • 8.1 Global Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.2 United States Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.3 Europe Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.4 China Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.5 Japan Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.6 India Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    • 8.7 South Korea Ischemia Reperfusion Injury Consumption Forecast (2022-2028)

    9 Global Ischemia Reperfusion Injury Market Outlook by Types and Applications to 2022

    • 9.1 Global Ischemia Reperfusion Injury Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ischemia Reperfusion Injury Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Heart Injury Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Kidney Injury Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Intestine Injury Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Injury Consumption and Growth Rate (2017-2022)

    10 Global Ischemia Reperfusion Injury Market Outlook by Types and Applications to 2028

    • 10.1 Global Ischemia Reperfusion Injury Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Ischemia Reperfusion Injury Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Heart Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Kidney Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Intestine Injury Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Injury Consumption Forecast and Growth Rate (2022-2028)

    11 Global Ischemia Reperfusion Injury Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Ischemia Reperfusion Injury Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Ischemia Reperfusion Injury Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Ischemia Reperfusion Injury Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Ischemia Reperfusion Injury Market Competitive Analysis

    • 14.1 Pharming

      • 14.1.1 Pharming Company Details

      • 14.1.2 Pharming Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pharming Ischemia Reperfusion Injury Product and Service

    • 14.2 Bolder Biotechnology

      • 14.2.1 Bolder Biotechnology Company Details

      • 14.2.2 Bolder Biotechnology Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bolder Biotechnology Ischemia Reperfusion Injury Product and Service

    • 14.3 SBI Pharmaceuticals

      • 14.3.1 SBI Pharmaceuticals Company Details

      • 14.3.2 SBI Pharmaceuticals Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Product and Service

    • 14.4 Opsona Therapeutics

      • 14.4.1 Opsona Therapeutics Company Details

      • 14.4.2 Opsona Therapeutics Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Product and Service

    • 14.5 TheraSource

      • 14.5.1 TheraSource Company Details

      • 14.5.2 TheraSource Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 TheraSource Ischemia Reperfusion Injury Product and Service

    • 14.6 Mifcortx

      • 14.6.1 Mifcortx Company Details

      • 14.6.2 Mifcortx Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Mifcortx Ischemia Reperfusion Injury Product and Service

    • 14.7 Prothix

      • 14.7.1 Prothix Company Details

      • 14.7.2 Prothix Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Prothix Ischemia Reperfusion Injury Product and Service

    • 14.8 Balmes Transplantation

      • 14.8.1 Balmes Transplantation Company Details

      • 14.8.2 Balmes Transplantation Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Balmes Transplantation Ischemia Reperfusion Injury Product and Service

    • 14.9 Angion Biomedica

      • 14.9.1 Angion Biomedica Company Details

      • 14.9.2 Angion Biomedica Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Angion Biomedica Ischemia Reperfusion Injury Product and Service

    • 14.10 Ischemix Inc

      • 14.10.1 Ischemix Inc Company Details

      • 14.10.2 Ischemix Inc Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Ischemix Inc Ischemia Reperfusion Injury Product and Service

    • 14.11 Corline Biomedical

      • 14.11.1 Corline Biomedical Company Details

      • 14.11.2 Corline Biomedical Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Corline Biomedical Ischemia Reperfusion Injury Product and Service

    • 14.12 Hope Pharmaceuticals

      • 14.12.1 Hope Pharmaceuticals Company Details

      • 14.12.2 Hope Pharmaceuticals Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Product and Service

    • 14.13 NovelMed Therapeutics

      • 14.13.1 NovelMed Therapeutics Company Details

      • 14.13.2 NovelMed Therapeutics Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 NovelMed Therapeutics Ischemia Reperfusion Injury Product and Service

    • 14.14 Omeros Corp

      • 14.14.1 Omeros Corp Company Details

      • 14.14.2 Omeros Corp Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Omeros Corp Ischemia Reperfusion Injury Product and Service

    • 14.15 Catalyst Biosciences

      • 14.15.1 Catalyst Biosciences Company Details

      • 14.15.2 Catalyst Biosciences Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Catalyst Biosciences Ischemia Reperfusion Injury Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Ischemia Reperfusion Injury

    • Figure Ischemia Reperfusion Injury Picture

    • Table Global Ischemia Reperfusion Injury Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ischemia Reperfusion Injury Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Ischemia Reperfusion Injury Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Ischemia Reperfusion Injury Consumption by Country (2017-2022)

    • Figure United States Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Table Europe Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure China Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure Japan Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure India Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ischemia Reperfusion Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Ischemia Reperfusion Injury Consumption Forecast by Country (2022-2028)

    • Figure United States Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ischemia Reperfusion Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Intestine Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Other Injury Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intestine Injury Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Injury Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Ischemia Reperfusion Injury Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Ischemia Reperfusion Injury Export by Region (Top 5 Countries) (2017-2028)

    • Table Pharming (Foundation Year, Company Profile and etc.)

    • Table Pharming Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharming Ischemia Reperfusion Injury Product and Service

    • Table Bolder Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Bolder Biotechnology Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bolder Biotechnology Ischemia Reperfusion Injury Product and Service

    • Table SBI Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table SBI Pharmaceuticals Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table SBI Pharmaceuticals Ischemia Reperfusion Injury Product and Service

    • Table Opsona Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Opsona Therapeutics Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opsona Therapeutics Ischemia Reperfusion Injury Product and Service

    • Table TheraSource (Foundation Year, Company Profile and etc.)

    • Table TheraSource Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table TheraSource Ischemia Reperfusion Injury Product and Service

    • Table Mifcortx (Foundation Year, Company Profile and etc.)

    • Table Mifcortx Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mifcortx Ischemia Reperfusion Injury Product and Service

    • Table Prothix (Foundation Year, Company Profile and etc.)

    • Table Prothix Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothix Ischemia Reperfusion Injury Product and Service

    • Table Balmes Transplantation (Foundation Year, Company Profile and etc.)

    • Table Balmes Transplantation Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Balmes Transplantation Ischemia Reperfusion Injury Product and Service

    • Table Angion Biomedica (Foundation Year, Company Profile and etc.)

    • Table Angion Biomedica Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Angion Biomedica Ischemia Reperfusion Injury Product and Service

    • Table Ischemix Inc (Foundation Year, Company Profile and etc.)

    • Table Ischemix Inc Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ischemix Inc Ischemia Reperfusion Injury Product and Service

    • Table Corline Biomedical (Foundation Year, Company Profile and etc.)

    • Table Corline Biomedical Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corline Biomedical Ischemia Reperfusion Injury Product and Service

    • Table Hope Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Hope Pharmaceuticals Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hope Pharmaceuticals Ischemia Reperfusion Injury Product and Service

    • Table NovelMed Therapeutics (Foundation Year, Company Profile and etc.)

    • Table NovelMed Therapeutics Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table NovelMed Therapeutics Ischemia Reperfusion Injury Product and Service

    • Table Omeros Corp (Foundation Year, Company Profile and etc.)

    • Table Omeros Corp Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omeros Corp Ischemia Reperfusion Injury Product and Service

    • Table Catalyst Biosciences (Foundation Year, Company Profile and etc.)

    • Table Catalyst Biosciences Ischemia Reperfusion Injury Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalyst Biosciences Ischemia Reperfusion Injury Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US